IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Integrative Cancer Therapies

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

2.64

h-Index

2022-2023

 66

Rank

2022-2023

 6339

SJR

2022-2023

 0.766

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Integrative Cancer Therapies
Abbreviation Integr. Cancer Ther.
Publication Type Journal
Subject Area, Categories, Scope Complementary and Alternative Medicine (Q1); Oncology (Q2)
h-index 66
Overall Rank/Ranking 6339
SCImago Journal Rank (SJR) 0.766
Impact Score 2.64
Publisher SAGE Publications Inc.
Country United States
ISSN 1552695X, 15347354
Best Quartile Q1
Coverage History 2002-2022




Aim and Scope


Integrative Cancer Therapies focuses on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments. The journal presents scientifically rigorous original research, case studies, current literature reviews, educational roundtables, and commentary on key topics such as: treatment strategies.


About Integrative Cancer Therapies


Integrative Cancer Therapies is a journal covering the technologies/fields/categories related to Complementary and Alternative Medicine (Q1); Oncology (Q2). It is published by SAGE Publications Inc.. The overall rank of Integrative Cancer Therapies is 6339. According to SCImago Journal Rank (SJR), this journal is ranked 0.766. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 66. The best quartile for this journal is Q1.

The ISSN of Integrative Cancer Therapies journal is 1552695X, 15347354. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Integrative Cancer Therapies is cited by a total of 1111 articles during the last 3 years (Preceding 2022).


Integrative Cancer Therapies Impact IF 2022-2023


The Impact IF 2022 of Integrative Cancer Therapies is 2.64, which is computed in 2023 as per its definition. Integrative Cancer Therapies IF is decreased by a factor of 0.3 and approximate percentage change is -10.2% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Integrative Cancer Therapies Impact IF 2023 Prediction


Impact IF 2022 of Integrative Cancer Therapies is 2.64. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Integrative Cancer Therapies. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 2.64
2021 2.94
2020 2.88
2019 2.49
2018 2.44
2017 2.21
2016 2.01
2015 2.28
2014 2.55

Integrative Cancer Therapies h-index


  Table Setting

Integrative Cancer Therapies has an h-index of 66. It means 66 articles of this journal have more than 66 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Integrative Cancer Therapies ISSN


The ISSN of Integrative Cancer Therapies is 1552695X, 15347354. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Integrative Cancer Therapies Rank and SCImago Journal Rank (SJR)


The overall rank of Integrative Cancer Therapies is 6339. According to SCImago Journal Rank (SJR), this journal is ranked 0.766. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Integrative Cancer Therapies by Year


Year SJR
2023/2024 Coming Soon
2022 0.766
2021 0.642
2020 0.730
2019 0.708
2018 0.806
2017 0.766
2016 0.630
2015 0.858
2014 0.681

Ranking of Integrative Cancer Therapies by Year


Year Ranking
2023/2024 Coming Soon
2022 6339
2021 7627
2020 6767
2019 6879
2018 5854
2017 6116
2016 7506
2015 5403
2014 6850

Integrative Cancer Therapies Publisher


Table Setting

Integrative Cancer Therapies is published by SAGE Publications Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 2002-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Integrative Cancer Therapies is Integr. Cancer Ther.. This abbreviation ('Integr. Cancer Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Integrative Cancer Therapies


If your research field is/are related to Complementary and Alternative Medicine (Q1); Oncology (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Integrative Cancer Therapies?

Integrative Cancer Therapies latest impact IF is 2.64. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.94 (2021) and 2.01 (2016), respectively, in the last 9 years. Moreover, its average IS is 2.49 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Integrative Cancer Therapies?

The Integrative Cancer Therapies has an SJR (SCImago Journal Rank) of 0.766, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.858 in 2015 and the lowest being 0.630 in 2016. Furthermore, the average SJR of the Integrative Cancer Therapies over the previous 9-year period stands at 2.49.


What's the latest h-index of the Integrative Cancer Therapies?

The latest h-index of the Integrative Cancer Therapies is 66.


Who's the publisher of the Integrative Cancer Therapies?

The Integrative Cancer Therapies is published by the SAGE Publications Inc., with its country of publication being the United States.


What's the current ranking of the Integrative Cancer Therapies?

The Integrative Cancer Therapies is currently ranked 6339 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 5403 in 2015 and its lowest position of 7627 in 2021.


What's the abbreviation or short name for the Integrative Cancer Therapies?

The standard ISO4 abbreviation for the Integrative Cancer Therapies is Integr. Cancer Ther..


Is the "Integrative Cancer Therapies" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Integrative Cancer Therapies is classified as a journal that the SAGE Publications Inc. publishes.


What's the scope or major areas of the Integrative Cancer Therapies?

The Integrative Cancer Therapies encompasses the following areas:

  • Complementary and Alternative Medicine
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Integrative Cancer Therapies?

The Integrative Cancer Therapies is assigned the following International Standard Serial Numbers (ISSN): 1552695X, 15347354.


What's the best quartile of the Integrative Cancer Therapies?

The best quartile for the Integrative Cancer Therapies is Q1 (2022).


What's the coverage history of the Integrative Cancer Therapies?

The Integrative Cancer Therapies coverage history can be summarized as follows: 2002-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 10343 Vilnius Gediminas Technical University 45 2.81
Zeitschrift fur Germanistische Linguistik journal 22945 De Gruyter Mouton 15 0.19
Milan Journal of Mathematics journal 3120 Birkhauser Verlag Basel 28 1.79
International Journal of Research and Method in Education journal 5180 Taylor and Francis Ltd. 34 2.49
Studies in Continuing Education journal 6011 Routledge 38 2.81
Natural Solutions trade journal 28581 Innovision Health Media 1 0.00
Epigenetics journal 2362 Landes Bioscience 105 4.11
Journal of Immigrant and Refugee Studies journal 9246 Routledge 32 1.46
Proteomics - Clinical Applications journal 9140 Wiley-VCH Verlag 59 2.02
Journal of Imaging Science and Technology journal 19249 Society for Imaging Science and Technology 44 0.96

Check complete list




Year wise Impact Score (IS) of Integrative Cancer Therapies

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.64
2021 2.94
2020 2.88
2019 2.49
2018 2.44
2017 2.21
2016 2.01
2015 2.28
2014 2.55



Top Journals/Conferences in Complementary and Alternative Medicine

GeroScience
Springer International Publishing AG | Switzerland

Phytomedicine
Urban und Fischer Verlag Jena | Germany

Journal of Ginseng Research
The Korean Society of Ginseng | Netherlands

Journal of Natural Products
American Chemical Society | United States

American Journal of Chinese Medicine
World Scientific Publishing Co. Pte Ltd | Singapore

Cannabis and Cannabinoid Research
Mary Ann Liebert Inc. | United States

Journal of Ethnobiology and Ethnomedicine
BioMed Central Ltd. | United Kingdom

Chinese Medicine
BioMed Central Ltd. | United Kingdom

Medical Cannabis and Cannabinoids
S. Karger AG | Switzerland

Journal of Traditional and Complementary Medicine
Elsevier BV | Netherlands

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All